NCT05629494 - Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test | Biotech Hunter

Enrollment

198

Participants

Timeline

Start Date

September 27, 2022

Primary Completion Date

March 1, 2026

Study Completion Date

December 1, 2026

Conditions

Prostate CancerProstate InflammationPSA

Interventions

DRUG

Ibuprofen 400 mg, TID

Participants will receive Ibuprofen 400 mg 3 times per day for 10 days.

DIAGNOSTIC_TEST

PSA test

PSA test will be repeated in 6 weeks

Trial Locations (3)

RECRUITING

Albany Medical Center, Albany

RECRUITING

Penn State-Hershey Medical Center, Hershey

RECRUITING

University of Chicago Medical Center, Chicago